Literature DB >> 1328919

D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.

B Borowsky1, C M Kuhn.   

Abstract

A stimulatory role for endogenous dopamine (DA) in the regulation of hypothalamo-pituitary-adrenal activity has previously been demonstrated. In the present study, the roles of D1 and D2 subtypes of DA receptors in the regulation of activity of the hypothalamo-pituitary-adrenal axis were investigated. The intraperitoneal administration of either the D1 agonist, SKF 383393 (1-phenyl-2,3,4,5 tetrahydro-(iH)-benzazepine-7,8diol HCl, 5-20 mg/kg) or the D2 agonist quinpirole (0.05-1 mg/kg) dose-dependently elevated both adrenocorticotropic hormone (ACTH) and corticosterone (CS) in serum. Similarly, administration of either SKF 38393 or quinpirole (1-100 micrograms) into the third ventricle dose-dependently elevated ACTH in serum. The response of ACTH to intraperitoneal SKF 38393 was blocked by pretreatment with the D1 antagonist SCH 23390 (1-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5 tetrahydro-1H-3-benzazepine, 0.25 mg/kg, i.p.) but not by the D2 antagonist sulpiride (50 mg/kg, i.p.). The response of ACTH to intraperitoneal injection of quinpirole was blocked by pretreatment with sulpiride and attenuated slightly by pretreatment with SCH 23390. Further, the co-administration of sub-maximum doses of SKF 38393 and quinpirole caused additive increases in ACTH in serum. These results suggest that both D1 and D2 subtypes of DA receptors contribute to the dopaminergic regulation of function of the hypothalamo-pituitary-adrenal axis and support a role for DA neurons in the hypothalamus in this response. Further, these findings suggest that the D1 and D2 receptors, mediating the response of the hypothalamopituitary-adrenal axis are not tightly coupled.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328919     DOI: 10.1016/0028-3908(92)90145-f

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  17 in total

1.  Constitutive somatostatin receptor activity determines tonic pituitary cell response.

Authors:  Anat Ben-Shlomo; Cuiqi Zhou; Oxana Pichurin; Vera Chesnokova; Ning-Ai Liu; Michael D Culler; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2009-01-08

2.  Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.

Authors:  M Schwendt; J F McGinty
Journal:  Neuroscience       Date:  2010-03-15       Impact factor: 3.590

3.  Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects.

Authors:  S D Schlussman; J Cassin; Y Zhang; O Levran; A Ho; M J Kreek
Journal:  Pharmacol Biochem Behav       Date:  2011-07-23       Impact factor: 3.533

4.  Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response.

Authors:  Celina Y Mojica; Jasmin M Dao; Menglu Yuan; Sandra E Loughlin; Frances M Leslie
Journal:  Neuropharmacology       Date:  2013-10-22       Impact factor: 5.250

5.  Revealing the Neuroendocrine Response After Remoxipride Treatment Using Multi-Biomarker Discovery and Quantifying It by PK/PD Modeling.

Authors:  Willem J van den Brink; Yin C Wong; Berfin Gülave; Piet H van der Graaf; Elizatbeth C M de Lange
Journal:  AAPS J       Date:  2016-10-26       Impact factor: 4.009

Review 6.  Genetics of dopamine receptors and drug addiction.

Authors:  Philip Gorwood; Yann Le Strat; Nicolas Ramoz; Caroline Dubertret; Jean-Marie Moalic; Michel Simonneau
Journal:  Hum Genet       Date:  2012-02-17       Impact factor: 4.132

7.  Dopamine D1 and D2 dopamine receptors regulate immobilization stress-induced activation of the hypothalamus-pituitary-adrenal axis.

Authors:  Xavier Belda; Antonio Armario
Journal:  Psychopharmacology (Berl)       Date:  2009-07-21       Impact factor: 4.530

8.  Bromocriptine-induced hyperglycemia in nonobese diabetic mice: kinetics and mechanisms of action.

Authors:  Sylvie Durant; Josiane Coulaud; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2007-11-10

9.  Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems.

Authors:  Susanne Becker; Petra Schweinhardt
Journal:  Pain Res Treat       Date:  2011-10-02

10.  Neurophysiological effects of sleep deprivation in healthy adults, a pilot study.

Authors:  Ursula M H Klumpers; Dick J Veltman; Marie-Jose van Tol; Reina W Kloet; Ronald Boellaard; Adriaan A Lammertsma; Witte J G Hoogendijk
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.